SEC Form 4 · accession 0001209191-16-091700
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Watt
Officer — VP, Finance
Period of report
Jan 6, 2016
Accepted (ET)
Jan 15, 2016 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $8.47 | Jan 6, 2016 | A | 25,000 | A | — | Jan 5, 2026 | Common Stock | 25,000 | 25,000 | D |
| Restricted Stock UnitsF2,F3 | $0.00 | Jan 6, 2016 | A | 12,500 | A | — | — | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1Vests as to 6.25% of the shares on 4/6/2016 and further vests as to an additional 6.25% of the original grant at the end of each successive three-month period thereafter until 1/6/2020.
- F2Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration.
- F3The restricted stock units vest in three equal installments on each of January 6, 2017, January 6, 2018 and January 6, 2019.